Nov 29, 2023 8:05am EST Ensysce Biosciences Announces Completion of $1.7 Million Convertible Note Financing
Nov 28, 2023 8:15am EST Ensysce Biosciences and OncoZenge Announce Letter of Intent for the Co-development of BupiZenge(TM) in the United States
June 14, 2023 Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO
May 17, 2023 As the White House attempts to expand overdose treatment, Ensysce is planning to provide pain relief with overdose protection.